Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

       
Total article views   HTML views PDF downloads Totals
13,378 Dovepress* 10,705+ 1,896 12,601
PubMed Central* 2,673 735 3,408
Totals 13,378 2,631 16,009
*Since 23 March 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar